Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Differentiated Thyroid Gland Carcinoma”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Not applicableLooking for participantsNCT06431620
What this trial is testing

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Who this might be right for
Recombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University 15
Testing effectiveness (Phase 2)Study completedNCT00121628
What this trial is testing

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Amgen 184
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193186
What this trial is testing

Anlotinib and Benmelstobart in DTC

Who this might be right for
Thyroid Cancer
Fudan University 23
Testing effectiveness (Phase 2)Study completedNCT04321954
What this trial is testing

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Who this might be right for
Differentiated Thyroid CancerAdvanced Cancer
Massachusetts Eye and Ear Infirmary 29
Not applicableUnknownNCT06062563
What this trial is testing

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
Peking Union Medical College Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT06558981
What this trial is testing

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Who this might be right for
Thyroid Cancer
Fudan University 124
Testing effectiveness (Phase 2)Study completedNCT00124527
What this trial is testing

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Eisai Inc. 35
Large-scale testing (Phase 3)UnknownNCT03048877
What this trial is testing

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Peking Union Medical College Hospital 118
Large-scale testing (Phase 3)Study completedNCT01876784
What this trial is testing

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 238
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07823686
What this trial is testing

Tracheal Replacement Using A Cryopreserved Aortic Allograft For R0 Resection In Locally Advanced Thyroid Cancer (TRITON 02 Tracheal Replacement In ThyrOid caNcer)

Who this might be right for
Differentiated Thyroid Cancer
Assistance Publique - Hôpitaux de Paris 80
Large-scale testing (Phase 3)Looking for participantsNCT06860971
What this trial is testing

AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 144
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06713057
What this trial is testing

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland CarcinomaThyroid Cancer
West China Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06970353
What this trial is testing

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

Who this might be right for
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848920
What this trial is testing

Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)Neoadjuvant Therapy
Zhejiang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06359847
What this trial is testing

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093
What this trial is testing

Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib

Who this might be right for
DTC - Differentiated Thyroid Cancer
Yansong Lin 20
Not applicableLooking for participantsNCT06405217
What this trial is testing

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Who this might be right for
DTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications
Nanjing First Hospital, Nanjing Medical University 30
Testing effectiveness (Phase 2)WithdrawnNCT04731740
What this trial is testing

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaThyroid Gland Anaplastic Carcinoma by AJCC V8 Stage
Saint Petersburg State University, Russia
Next Page